Navigation Links
Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
Date:1/25/2008

://www.clinicaltrials.gov (search for Catalyst).

Patrick J. McEnany, Chief Executive Officer of Catalyst, commented: "We are very pleased to announce the start of active enrollment in our study of CPP-109 as a potential treatment for cocaine addiction. We expect to add more clinical trial sites to the 10 previously disclosed in order to complete the trial as soon as possible. We anticipate initial top-line results from this trial to be available by year-end."

Douglas Winship, Catalyst's Vice President of Regulatory Operations, stated: "Vigabatrin has previously shown the potential to be a safe and effective non-addictive drug treatment for cocaine and methamphetamine addiction in a Phase II double-blind, placebo-controlled trial and two pilot studies conducted in Mexico. We are excited to now evaluate the therapeutic benefit of CPP-109 in cocaine-addicted patients enrolled in a large, double- blind, placebo-controlled trial conducted in the U.S. under our sponsorship. There are currently no prescription drugs approved for the treatment of this population. As a result, drug therapies are desperately needed which can improve abstinence achievement rates of behavioral therapy administered by addiction treatment specialists, and reduce recidivism. We have worked diligently with regulatory authorities and the independent institutional review boards at each of the clinical sites where our trial will be conducted to be able to finalize and implement our protocol for this trial."

On December 7, 2007, Catalyst announced positive initial top-line results from a 103-patient, investigator-initiated Phase II double-blind, placebo- controlled trial, in which vigabatrin met its primary efficacy endpoint of abstinence during the last weeks of treatment for cocaine addiction. Additional results of this study will be reported when they become available.

About CPP-109

CPP-109 works by inhibiting an enzyme that normally breaks down gamma aminobuty
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
3. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
4. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
5. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
6. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
7. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
8. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
9. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
10. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
11. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Tenn., Dec. 15 Medical researchers with ... with their revolutionary new technology for a simple ... ,, Following the success of its pre-clinical ... a patent on the biomarker, CA11-19, and all ... blood test, ColoMarker(TM) will detect colon cancer in ...
(Date:12/15/2009)... Tenn., Dec. 15 Cumberland Pharmaceuticals ... announced new top-line results for a patient ... Oral Solution, a prescription laxative packaged as a ... forms. ,, Kristalose is the only prescription-strength laxative ... period, 50 patients with a recent diagnosis of ...
(Date:12/15/2009)... 15 Today,s New York ... for Kidney Drugs Spurs Division," illustrates an internal ... kidney patients continuing to be deprived of their ... program limit. ,, As Congress is poised to ... the lives of transplant kidney recipients, behind-the-scenes debate ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2SemBioSys securityholder vote to be held December 18 2009 with a record date of November 16 2009 14878 1SemBioSys securityholder vote to be held December 18 2009 with a record date of November 16 2009 14878 2SemBioSys securityholder vote to be held December 18 2009 with a record date of November 16 2009 14878 3VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 6356 1VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 6356 2Cancer patients and doctors report drug side effects differently 61571 1Cancer patients and doctors report drug side effects differently 61571 2
(Date:12/15/2009)... WASHINGTON, Dec. 15 The Food and Health ... Kong and overseas parties in developing private hospitals at ... The deadline for submitting EOI is March 31, 2010. ... Food and Health, Dr. York Chow, said the promotion ... under healthcare reform and a major Hong Kong government ...
(Date:12/15/2009)... -- Our Lady of Lourdes Health Care Services Inc., ... agreed to pay the United States $7.95 million to ... Department announced today. The two hospitals are Our Lady ... Lourdes Medical Center of Burlington County (LMC) in Willingboro, ... suit brought by a whistleblower, Tony Kite, in 2005. ...
(Date:12/15/2009)... flu were worse, ,we would have really been in ... -- The outbreak of the pandemic H1N1 swine flu ... respond to public health emergencies, a new report says. ... Health and the Robert Wood Johnson Foundation, also finds ... health system. , "The 2009 H1N1 outbreak is the ...
(Date:12/15/2009)... education program will train advocates to be leaders ... Project developed with support from experts in online ... ,, WASHINGTON, Dec. 15 ... are accepting applications for the first-ever "Malaria Griots" ... and educate participants to become leaders in the ...
(Date:12/15/2009)... -- Patient advocate Betsy McCaughey, ... Congress that, "it doesn,t matter whether there,s a public ... a public option - give government authority over how ... a new social agenda by shifting billions of dollars ... arriving immigrants, and local politicians." ,, Betsy ...
Breaking Medicine News(10 mins):Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... potential savings of $6 million in early tenure turnover costs. ... ... Infohrm , the global leader in workforce planning, reporting and analytics ... of its member client WellPoint, Inc.,s workforce analytics program. Through ...
... NXTware Remote Studio, an Eclipse plug-in, improve HP OpenVMS productivity without ... ... -- eCube Systems, a leader in legacy systems evolution, today announced ... NXTware Remote Studio for the HP OpenVMS platform., , ,The products, ...
... High Demand for Nursing School Graduates with Bachelor,s Degrees , ... Houston, ... University of St. Thomas in Houston recently voted to reopen the ... , ,The St. Thomas Nursing School operated from 1972 to 1986, when ...
... has begun to help,United Healthcare Workers-West members fight ... Employees International Union President and,Secretary-Treasurer., "A Salute ... SEIU,United Health Care Workers-West and their President, Sal ... 7:30 at the Julia Morgan,Ballroom, Merchants Exchange Building, ...
... cooler months, WASHINGTON, Nov. 10 "Home fire season" ... make this year,s cold,months safer than last years -- when ... the USFA, during the "home fire season" of,October 2007 to ... of fatal,home fires and a 67% increase in the number ...
... Epidemic linked to hypertension, obesity, diabetes, study shows , , ... heart failure among older Americans have increased dramatically in ... mounting burden on the health-care system, a new study ... men and women over 65 were hospitalized for heart ...
Other Medicine News:Health News:Infohrm Member Client Saves Millions of Dollars Through Workforce Analytics 2Health News:Infohrm Member Client Saves Millions of Dollars Through Workforce Analytics 3Health News:eCube Systems Brings Remote Eclipse Development to HP OpenVMS 2Health News:eCube Systems Brings Remote Eclipse Development to HP OpenVMS 3Health News:University of St. Thomas Houston to Reopen Nursing School 2Health News:Health Care Workers Get Help Fighting Unprecedented Attacks from Service Employee International Union Leadership 2Health News:U.S. Fire Administration Seeks a Safer 'Home Fire Season' 2Health News:U.S. Fire Administration Seeks a Safer 'Home Fire Season' 3Health News:Heart Failure Hospitalizations Up Sharply 2Health News:Heart Failure Hospitalizations Up Sharply 3
The MYO-VAD is a novel cardiac support system with unique, life-saving features....
... 7500 incorporates SPO Medical's unique reflectance ... for maximum user comfort and ease-of-use. ... for extended usage, eliminating the need ... 7500 downloads stored readings to a ...
ABX Micros IM Hematology Analyzer for a rapid diagnostic...
... Certus guidewire from Radi Medical Systems ... for guiding intervention in patients with ... Reserve (FFR)., ,Enhanced handling properties include ... strengthened core wire linking tip to ...
Medicine Products: